Business
“Reality check”: In early data, AstraZeneca vaccine offers minimal protection against South African variant – Sydney Morning Herald
Australian health authorities have backed AstraZeneca’s vaccine despite South Africa’s decision to pause roll-out of the jab, after early clinical data showed it…
It remains unclear if the vaccine will still protect against serious illness and death; scientists who were part of the South African trial are hopeful it will.
The University of Oxford, which co-developed the vaccine, said it was working on a booster jab to provide protection against the variant, if necessary.
CSL, which is contracted by the government and AstraZeneca to produce 50 million doses of the vaccine at its Broadmeadows plant, did not comment directly on whether it could modify the jab…
-
Noosa News24 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General18 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General21 hours agoReason v magical climate thinking – voters have no choice
-
General17 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues